
Uncategorized - August 7, 2013
Teva initiates Huntington’s study
Teva Pharmaceutical is starting a global research collaboration to examine multiple pathways of neuroprotection in Huntington’s disease. Teva Pharmaceutical Industries Ltd. recently announced the formation of a research collaboration to “create a comprehensive understanding and drive insights into neuroprotective therapeutic approaches” in Huntington’s disease, a neurodegenerative genetic disorder that affects muscle coordination and leads to […]